To meet a broad range of skin health needs, we offer a range of leading medical and consumer skin health brands, through three business units: Prescription, Aesthetics (both under the Galderma brand), and Consumer care.
Key facts
7 innovation areas
We focus our innovation on 7 areas: acne, rosacea, psoriasis, atopic dermatitis, skin ageing, sun protection and skin cancer.
6 manufacturing sites
In 2017, the 1,200+ employees at our 6 manufacturing sites produced 215 million units. We make 75% of our products in-house.
World presence
We operate from 50 sites in 40 countries, with our headquarters in Lausanne, Switzerland.
Sales by region
North America 49%
International 51%
Sales by business
Consumer 43%
Aesthetics 32%
Prescription 25%
Creating shared value
We collaborate with the broad skin health community:
-
Industry-leading medical education with Derm101
-
Promoting community initiatives in dermatology
-
Engaging with the dermatology community
CSR Policy Financial Year 2017-2018
CSR Policy Financial Year 2018-2019
A timeline of our history
1981
Foundation of Galderma
1984
Galderma discovers Adapalene
2004
Opening of production site in Hortolândia, Brazil
2007
Launch of Differin 0.3%
2008
Launch of Epiduo
2009
Launch of Azzalure and Restylane Injector